Missouri & Illinois Personal Injury Attorneys
Call 24/7 800.391.4318
Xarelto Cases Build As Trials Near

Xarelto Cases Build As Trials Near

Have you or a loved one experienced a bleeding injury due to the blood thinner Xarelto? If so, you’re not alone. Hundreds of patients have sustained uncontrollable bleeding injuries, and some have resulted in fatalities. A class action lawsuit has been filed against Bayer and Johnson & Johnson Janssen Pharmaceuticals, the manufacturers of Xarelto. Recently, trials have been set in the multi-district litigation, and those who have suffered from Xarelto’s side effects are encouraged to contact an attorney immediately.

The U.S. Food & Drug Administration approved Xarelto to treat deep vein thrombosis, pulmonary embolism and prevent individuals with atrial fibrillation from suffering a stroke. Xarelto is being promoted as a convenient option for those requiring the use of anticoagulants, blood thinner drugs. Coumadin and Warfarin have been on the market for several years prior to Xarelto’s approval. These anticoagulants require an altered diet and regular monitoring unlike Xarelto. However, Xarelto does not have an antidote like the other drugs to reverse the effects of thinning the blood. In the event that an injury or illness occurs, it is difficult to control and stop the bleeding resulting in serious injuries and death. If you have suffered an injury or lost a loved one due to Xarelto’s side effects, it is imperative to consult an experienced St. Louis area Xarelto attorney.

The personal injury attorneys at Meyerkord & Meyerkord, LLC have handled numerous dangerous drug cases and will work diligently on your case. Our attorneys have recovered over $350 million in compensation for our clients and will fight to recover the maximum compensation for your case. Contact us to receive a free no-obligation consultation today.


Take the First Step Towards Recovery

Put Experience On Your Side Today
    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.